Development and validation of lens-free polarized microscopy to identify mono-sodium urate and calcium pyrophosphate crystals from synovial fluid
Development and validation of lens-free polarized microscopy to identify mono-sodium urate and calcium pyrophosphate crystals from synovial fluid
批准号:
9761457
负责人:
JOHN D FITZGERALD
金额:
$17.16万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-09 至 2021-05-31
关键词:
AffectAgreementAlgorithmsArthritisAutomationBirefringenceCalcium PyrophosphateCalcium pyrophosphate deposition diseaseCharacteristicsClinicalConsumptionCrystallizationDataDatabasesDepositionDetectionDevelopmentDevicesDiagnosisDiagnosticExaminations and DiagnosesGoldGoutImageInflammatory ArthritisJointsLight MicroscopeMethodologyMethodsMicroscopeMicroscopicMicroscopyModalityOpticsPatientsPolarization MicroscopyProcessPropertyPseudogoutResolutionSamplingScanningSynovial FluidSystemTechnologyTestingTimeUrateValidationWorkarthropathiesclinical applicationcostexperienceimage processingimprovedinstrumentinstrumentationlensparticlepolarized lightscreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Crystal arthropathy is the most common type of inflammatory arthritis, caused by the deposition of either
monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPP) crystals in or around joints, clinically
recognized as either gout or pseudogout. Diagnosis of crystal arthropathy can be established by identifying
MSU or CPPD crystals in the synovial fluid with a compensated polarized light microscope (CPLM). CPLM has
been the gold- standard diagnostic instrument for crystal arthropathy since 1961. However, given the limited
field of view (FOV) of CPLM, examination for crystals can be laborious. Furthermore, the sensitivity of CPLM
can be affected by crystal concentration, size, and birefringent properties (particularly for CPP crystals), as well
as technician experience. There exists the need to develop an inexpensive high-resolution, wide-FOV
polarized microscopic device for synovial fluid screening, with improved sensitivity.
Lens-free on-chip microscopy has developed in the past decade. The advantages of the lens-free microscope
include high-resolution, wide FOV, low cost and compact instrumentation. However, lens-free technology has
not been adapted to perform polarized imaging due to a fundamental difference in its imaging principle. We
have developed a way to overcome this challenge and have preliminary data showing the ability of our system
to accurately detect both MSU and CPP crystals.
The proposed lens-free polarized on-chip microscope will enable the rapid screening and sensitive detection of
birefringent crystals in synovial fluid samples of patients, greatly improving the sensitivity and efficiency of gout
and pseudogout diagnosis.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/srep28793
发表时间:
2016-06-30
期刊:
Scientific reports
影响因子:
4.6
作者:
[Zhang Y, Lee SY, Zhang Y, Furst D, Fitzgerald J, Ozcan A]
通讯作者:
Ozcan A
DOI:
10.1002/jbio.201960036
发表时间:
2020-01
期刊:
Journal of biophotonics
影响因子:
2.8
作者:
[Bai B, Wang H, Liu T, Rivenson Y, FitzGerald J, Ozcan A]
通讯作者:
Ozcan A
Diagnostic advances in synovial fluid analysis and radiographic identification for crystalline arthritis.
结晶性关节炎滑液分析和放射学鉴定的诊断进展。
DOI:
10.1097/bor.0000000000000582
发表时间:
2019
期刊:
Current opinion in rheumatology
影响因子:
5.1
作者:
[Zell,Monica, Zhang,Dawen, FitzGerald,John]
通讯作者:
FitzGerald,John
DOI:
10.1021/acsphotonics.0c01051
发表时间:
2020-11-18
期刊:
ACS photonics
影响因子:
7
作者:
[Liu T, de Haan K, Bai B, Rivenson Y, Luo Y, Wang H, Karalli D, Fu H, Zhang Y, FitzGerald J, Ozcan A]
通讯作者:
Ozcan A
Cutaneous uric acid and metabolite monitoring to improve individual response to pharmaceutical and dietary treatment in patients with gout
-
批准号:10642949
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2022
-
负责人:JOHN D FITZGERALD
-
依托单位:
Cutaneous uric acid and metabolite monitoring to improve individual response to pharmaceutical and dietary treatment in patients with gout
-
批准号:10436693
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2022
-
负责人:JOHN D FITZGERALD
-
依托单位:
Impact of Medicare policies on utilization and outcomes.
-
批准号:6530434
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2002
-
负责人:JOHN D FITZGERALD
-
依托单位:
Impact of Medicare policies on utilization and outcomes.
-
批准号:6915125
-
项目类别:
-
资助金额:$11.48万
-
财政年份:2002
-
负责人:JOHN D FITZGERALD
-
依托单位:
Impact of Medicare policies on utilization and outcomes.
-
批准号:6782505
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2002
-
负责人:JOHN D FITZGERALD
-
依托单位:
Impact of Medicare policies on utilization and outcomes.
-
批准号:6612845
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2002
-
负责人:JOHN D FITZGERALD
-
依托单位:
Potential impact of bundled Medicare payments
-
批准号:6480402
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2001
-
负责人:JOHN D FITZGERALD
-
依托单位:
Potential impact of bundled Medicare payments
-
批准号:6346727
-
项目类别:
-
资助金额:$15.94万
-
财政年份:1987
-
负责人:JOHN D FITZGERALD
-
依托单位:
海外基金